Update in Pharmacotherapy for Hypertension is organized by AchieveCE.

Description:
In 2014, a much-anticipated update to the 2003 JNC guidelines for hypertensive management were released. The 2014 update was met with mixed responses in the medical community and was further complicated by the results of the SPRINT trial in 2015. To address areas of controversy, a multi-organization consensus guideline was released in 2017. After an 11 year period of consistency, the plethora of guidelines releases has resulted in confusion in the clinical community. This activity will provide a clear overview of updated recommendations with a focus on drug therapy. It is relevant for new and experienced pharmacists, pharmacy technicians, nurses, and advanced practice providers.

What you will learn:
Pharmacist Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:

Recognize updates related to classification of hypertension and prehypertension
Identify patient-specific factors that guide selection of agents for hypertension
Determine strategies for addressing non-adherence to anti hypertensive therapy

Pharmacy Technician and Nurse Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:

Recognize the definition of hypertension.
Identify medications commonly used for the treatment of hypertension.
Identify general reasons why patients may be non-adherent to anti hypertensive medicines.